{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:46:50Z","timestamp":1794462410347,"version":"4.9.1"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82607984"],"award-info":[{"award-number":["82607984"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2026-JYB-XJSJJ018"],"award-info":[{"award-number":["2026-JYB-XJSJJ018"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pharmthera.2026.109121","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:07:12Z","timestamp":1789085232000},"page":"109121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting depression: Pharmacological mechanisms and therapeutic targets"],"prefix":"10.1016","volume":"288","author":[{"given":"Huiqin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8061","key":"10.1016\/j.pharmthera.2026.109121_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-025-08672-1","article-title":"A subcortical switchboard for perseverative, exploratory and disengaged states","volume":"641","author":"Ahmadlou","year":"2025","journal-title":"Nature"},{"issue":"7981","key":"10.1016\/j.pharmthera.2026.109121_bb0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-023-06541-3","article-title":"Cingulate dynamics track depression recovery with deep brain stimulation","volume":"622","author":"Alagapan","year":"2023","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109121_bb0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s12035-022-03102-z","article-title":"The dialogue between neuroinflammation and adult neurogenesis: Mechanisms involved and alterations in neurological diseases","volume":"60","author":"Amanollahi","year":"2023","journal-title":"Molecular Neurobiology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109121_bb0020","doi-asserted-by":"crossref","first-page":"eaec1444","DOI":"10.1126\/sciadv.aec1444","article-title":"TrkB\/mGluR5 cross-talk underlies a synaptic metaplasticity mechanism of ketamine","volume":"12","author":"Arefin","year":"2026","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0025","first-page":"1","article-title":"Hsp90 heterocomplexes regulate steroid hormone receptors: From stress response to psychiatric disease","volume":"20","author":"Baker","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0030","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/brain\/awaf355","article-title":"Inhibition of GluN2B-containing N-methyl-D-aspartate receptors by radiprodil","volume":"149","author":"Banke","year":"2026","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2018.06.015","article-title":"Prescribing antipsychotics in older people: A mini-review","volume":"116","author":"Behrman","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0040","doi-asserted-by":"crossref","unstructured":"Benoit, L., Hristovska, I., Liaudet, N., Jouneau, P.-H., Fertin, A., Ceglia, R. de, Litvin, D. G., di Castro, M. A., Jevtic, M., Zalachoras, I., Kikuchi, T., Telley, L., Bergami, M., & Yve, A. V. (2025). Astrocytes functionally integrate multiple synapses via specialized leaflet domains. Cell, 188(23), 6453\u20136472.e16. doi:https:\/\/doi.org\/10.1016\/j.cell.2025.08.036.","DOI":"10.1016\/j.cell.2025.08.036"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biological Psychiatry"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109121_bb0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","article-title":"Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment","volume":"36","author":"Binder","year":"2004","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109121_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.10609","article-title":"Genotype-guided antidepressant prescribing for patients with depression: A randomized clinical trial","volume":"9","author":"Blake","year":"2026","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0060","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41380-025-03229-0","article-title":"Interrelations between dopaminergic-, gabaergic- and glutamatergic neurotransmitters in antipsychotic-na\u00efve psychosis patients and the association to initial treatment response","volume":"31","author":"Bojesen","year":"2026","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41380-025-03218-3","article-title":"Dopaminergic frontostriatal pathways in major depressive disorder and childhood sexual abuse: A multimodal neuroimaging investigation","volume":"31","author":"Borchers","year":"2026","journal-title":"Molecular Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109121_bb0070","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/FBP.0000000000000659","article-title":"Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline","volume":"32","author":"Broadbear","year":"2021","journal-title":"Behavioural Pharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109121_bb0075","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1038\/s41380-024-02538-0","article-title":"Serotonin effects on human iPSC-derived neural cell functions: From mitochondria to depression","volume":"29","author":"Cardon","year":"2024","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0080","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1038\/s41467-026-73350-3","article-title":"TRIM21 facilitates inflammasome assembly and contributes to autoinflammatory disease","volume":"17","author":"Carriere","year":"2026","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2025.4303","article-title":"Psychiatric documentation and management in primary care with artificial intelligence scribe use","volume":"83","author":"Castro","year":"2026","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41398-025-03572-4","article-title":"[18F]FDG PET metabolic patterns of the rapid-acting antidepressant effects of NLX-101, a 5-HT1A receptor biased agonist","volume":"15","author":"Chaib","year":"2025","journal-title":"Translational Psychiatry"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109121_bb0095","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.scib.2025.04.010","article-title":"Multi-omic analyses of the development of obesity-related depression linked to the gut microbe Anaerotruncus colihominis and its metabolite glutamate","volume":"70","author":"Chang","year":"2025","journal-title":"Science Bulletin"},{"issue":"6709","key":"10.1016\/j.pharmthera.2026.109121_bb0100","doi-asserted-by":"crossref","DOI":"10.1126\/science.ado7010","article-title":"Brain region-specific action of ketamine as a rapid antidepressant","volume":"385","author":"Chen","year":"2024","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.6028","article-title":"Ventricular arrhythmia and sudden death risk with concomitant antipsychotic and SSRI use","volume":"9","author":"Chien","year":"2026","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0110","article-title":"Dopaminergic mechanisms supporting hippocampal postencoding dynamics in humans","volume":"123","author":"Ciampa","year":"2026","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10128","key":"10.1016\/j.pharmthera.2026.109121_bb0115","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109121_bb0120","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.neuron.2023.08.006","article-title":"Structure and dynamics of differential ligand binding in the human \u03c1-type GABAA receptor","volume":"111","author":"Cowgill","year":"2023","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","article-title":"Major depressive disorder: Hypothesis, mechanism, prevention and treatment","volume":"9","author":"Cui","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02424-y","article-title":"Connexin 43 gap junction-mediated astrocytic network reconstruction attenuates isoflurane-induced cognitive dysfunction in mice","volume":"19","author":"Dong","year":"2022","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2016.03.023","article-title":"Environmental and genetic determinants of childhood depression: The roles of DAT1 and the antenatal environment","volume":"197","author":"D\u2019Souza","year":"2016","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1021\/acs.chemrev.3c00375","article-title":"Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants","volume":"124","author":"Duan","year":"2024","journal-title":"Chemical Reviews"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41593-025-01891-9","article-title":"Astrocytic cannabinoid receptor 1 promotes resilience by dampening stress-induced blood\u2013brain barrier alterations","volume":"28","author":"Dudek","year":"2025","journal-title":"Nature Neuroscience"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109121_bb0150","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/s41386-023-01653-w","article-title":"Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence","volume":"48","author":"Dunlop","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109121_bb0155","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.neuron.2023.05.002","article-title":"NMDA receptor functions in health and disease: Old actor, new dimensions","volume":"111","author":"Dupuis","year":"2023","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109121_bb0160","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2020.19080848","article-title":"Hormonal treatments for major depressive disorder: State of the art","volume":"177","author":"Dwyer","year":"2020","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000535005","article-title":"Longitudinal clusters of Long-term trajectories in patients with early-onset chronic depression: 2 years of naturalistic follow-up after extensive psychological treatment","volume":"93","author":"Elsaesser","year":"2024","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109121_bb0170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-025-04154-z","article-title":"A short-acting psychedelic intervention for major depressive disorder: A phase IIa randomized placebo-controlled trial","volume":"32","author":"Erritzoe","year":"2026","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109121_bb0175","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.biopsych.2022.10.012","article-title":"Brain serotonin release is reduced in patients with depression: A [11C]Cimbi-36 positron emission tomography study with a d-amphetamine challenge","volume":"93","author":"Erritzoe","year":"2023","journal-title":"Biological Psychiatry"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109121_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aea4183","article-title":"In situ structure of the human gap junction","volume":"12","author":"Eshriew","year":"2026","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2026.03.012","article-title":"Noninvasive tactile stimulation engaging a thalamic-amygdala circuit ameliorates mood dysfunction in mouse models of depression-like behavior","author":"Fan","year":"2026","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0190","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/s41380-020-01004-x","article-title":"Chronic unpredictable stress induces depression-related behaviors by suppressing AgRP neuron activity","volume":"26","author":"Fang","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109121_bb0195","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/s41380-025-03387-1","article-title":"The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice","volume":"31","author":"Fleury","year":"2026","journal-title":"Molecular Psychiatry"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109121_bb0200","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s40265-016-0655-3","article-title":"Vortioxetine: A review in cognitive dysfunction in depression","volume":"76","author":"Frampton","year":"2016","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70624","article-title":"Mechanism-based polypharmacy as a repurposing strategy: The case of D-cycloserine and lurasidone","volume":"19","author":"Franzen","year":"2026","journal-title":"Clinical and Translational Science"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107918","article-title":"All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants","volume":"220","author":"Freudenberg","year":"2025","journal-title":"Pharmacological Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109121_bb0215","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41593-023-01351-2","article-title":"Gradients of neurotransmitter receptor expression in the macaque cortex","volume":"26","author":"Froudist-Walsh","year":"2023","journal-title":"Nature Neuroscience"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109121_bb0220","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/s41380-024-02531-7","article-title":"Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor","volume":"29","author":"Gaitonde","year":"2024","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02517-8","article-title":"FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus","volume":"19","author":"Gan","year":"2022","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-025-02143-7","article-title":"Explainable AI-driven precision clinical trial enrichment: Demonstration of the NetraAI platform with a phase II depression trial","volume":"8","author":"Geraci","year":"2025","journal-title":"NPJ Digital Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109121_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamaneurol.2021.4736","article-title":"Long-term effectiveness of adjuvant treatment with catechol-O-methyltransferase or monoamine oxidase B inhibitors compared with dopamine agonists among patients with Parkinson disease uncontrolled by levodopa therapy: The PD MED randomized clinical trial","volume":"79","author":"Gray","year":"2022","journal-title":"JAMA Neurology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0240","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biopsych.2023.05.023","article-title":"Pramipexole enhances reward learning by preserving value estimates","volume":"95","author":"Halahakoon","year":"2024","journal-title":"Biological Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109121_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109185","article-title":"Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5","volume":"35","author":"Hartmann","year":"2021","journal-title":"Cell Reports"},{"issue":"6747","key":"10.1016\/j.pharmthera.2026.109121_bb0250","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1126\/science.adx4559","article-title":"Extending ketamine's antidepressant effects","volume":"388","author":"Hashimoto","year":"2025","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109121_bb0255","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1038\/s41380-021-01044-x","article-title":"The co-chaperone Fkbp5 shapes the acute stress response in the paraventricular nucleus of the hypothalamus of male mice","volume":"26","author":"H\u00e4usl","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109121_bb0260","article-title":"Structural insights into constitutive activity of 5-HT6 receptor","volume":"120","author":"He","year":"2023","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109121_bb0265","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-021-00816-x","article-title":"Novel glutamatergic modulators for the treatment of mood disorders: Current status","volume":"35","author":"Henter","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115315","article-title":"Relationship of stress-reactive cortisol to suicidal intent of prior attempts in major depression","volume":"327","author":"Herzog","year":"2023","journal-title":"Psychiatry Research"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109121_bb0275","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1021\/acschemneuro.3c00591","article-title":"Classics in chemical neuroscience: Selegiline, isocarboxazid, phenelzine, and tranylcypromine","volume":"14","author":"Hoffman","year":"2023","journal-title":"ACS Chemical Neuroscience"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109121_bb0280","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.neuron.2024.02.019","article-title":"TGR5-mediated lateral hypothalamus-dCA3- dorsolateral septum circuit regulates depressive- like behavior in male mice","volume":"112","author":"Hong","year":"2024","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41582-023-00904-0","article-title":"Schizophrenia: From neurochemistry to circuits, symptoms and treatments","volume":"20","author":"Howes","year":"2024","journal-title":"Nature Reviews. Neurology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109121_bb0290","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41380-023-02193-x","article-title":"Brain-wide changes in excitation-inhibition balance of major depressive disorder: A systematic review of topographic patterns of GABA- and glutamatergic alterations","volume":"28","author":"Hu","year":"2023","journal-title":"Molecular Psychiatry"},{"issue":"8072","key":"10.1016\/j.pharmthera.2026.109121_bb0295","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41586-025-09083-y","article-title":"Single-cell transcriptomic and chromatin dynamics of the human brain in PTSD","volume":"643","author":"Hwang","year":"2025","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109121_bb0300","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.biopsych.2018.02.006","article-title":"The gamma-aminobutyric acid B receptor in depression and reward","volume":"83","author":"Jacobson","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109121_bb0305","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/j.neuron.2025.06.012","article-title":"The polypharmacology of psychedelics reveals multiple targets for potential therapeutics","volume":"113","author":"Jain","year":"2025","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0310","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/1570159X19666210517150418","article-title":"Off-label uses of selective serotonin reuptake inhibitors (SSRIs)","volume":"20","author":"Jannini","year":"2022","journal-title":"Current Neuropharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109121_bb0315","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamapsychiatry.2025.1811","article-title":"Dopamine and mood in psychotic disorders: An 18F-DOPA PET study","volume":"82","author":"Jauhar","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbi.2021.10.009","article-title":"Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression","volume":"99","author":"Ji","year":"2022","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108431","article-title":"The antidepressant actions of ketamine and its enantiomers","volume":"246","author":"Johnston","year":"2023","journal-title":"Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109121_bb0330","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/1039856218794874","article-title":"Milnacipran: Serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant","volume":"26","author":"Keks","year":"2018","journal-title":"Australasian Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0335","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-026-02398-9","article-title":"Kappa opioid receptor availability correlates with depressive symptom burden in chronic migraine: A preliminary investigation","volume":"27","author":"Kim","year":"2026","journal-title":"The Journal of Headache and Pain"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109121_bb0340","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s12276-023-01082-1","article-title":"Structure-based drug discovery of a corticotropin-releasing hormone receptor 1 antagonist using an X-ray free-electron laser","volume":"55","author":"Kim","year":"2023","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2026.05.005","article-title":"POINTseq: Cell-type-specific barcoding reveals single-cell projection architecture of the mouse dopaminergic system","author":"Kim","year":"2026","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109121_bb0350","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s12276-025-01399-z","article-title":"GluN2B-mediated regulation of silent synapses for receptor specification and addiction memory","volume":"57","author":"Kim","year":"2025","journal-title":"Experimental & Molecular Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109121_bb0355","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.molmed.2023.02.003","article-title":"Bridging rapid and sustained antidepressant effects of ketamine","volume":"29","author":"Kim","year":"2023","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0360","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41380-022-01824-z","article-title":"Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: A systematic review and network meta-analysis","volume":"28","author":"Kishi","year":"2023","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Translational Neurodegeneration"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0370","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tcb.2021.07.007","article-title":"Cellular mechanisms of connexin-based inherited diseases","volume":"32","author":"Laird","year":"2022","journal-title":"Trends in Cell Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0375","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1017\/S1092852924002360","article-title":"Association of antidepressants with cataracts and glaucoma: A disproportionality analysis using the reports to the United States Food and Drug Administration adverse event reporting system (FAERS) pharmacovigilance database","volume":"29","author":"Le","year":"2024","journal-title":"CNS Spectrums"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109121_bb0380","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/j.cell.2025.04.032","article-title":"Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis","volume":"188","author":"Li","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0385","article-title":"Towards real-time additive-free dopamine detection at 10(\u22128) mM with hardware accelerated platform integrated on camera","author":"Li","year":"2026","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0390","first-page":"0987","article-title":"Structural pharmacology of bufotenine derivatives in activating the 5-HT1A receptor for therapeutic potential in depression and anxiety","volume":"8","author":"Li","year":"2025","journal-title":"Research (Wash D C)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41467-025-66670-3","article-title":"Structural basis for pharmacotherapeutic action of triple reuptake inhibitors","volume":"17","author":"Li","year":"2026","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107494","article-title":"A hypothesis of monoamine (5-HT)\u2013glutamate\/GABA long neural circuit: Aiming for fast-onset antidepressant discovery","volume":"208","author":"Li","year":"2020","journal-title":"Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0405","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.biopsych.2024.07.017","article-title":"An Astroglial basis of major depressive disorder: Molecular, cellular, and circuit features","volume":"19","author":"Lu","year":"2025","journal-title":"Biological Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109121_bb0410","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","article-title":"GABAA receptors as targets for treating affective and cognitive symptoms of depression","volume":"44","author":"Luscher","year":"2023","journal-title":"Trends in Pharmacological Sciences"},{"issue":"June","key":"10.1016\/j.pharmthera.2026.109121_bb0415","article-title":"Antidepressant efficacy of agomelatine: Meta-analysis of placebo controlled and active comparator studies","volume":"65","author":"Maddukuri","year":"2021","journal-title":"Asian Journal of Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109121_bb0420","article-title":"The ISR downstream effector ATF4 promotes mGluR-dependent long-term depression and associated behavior","volume":"123","author":"Mahmood","year":"2026","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0425","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.cell.2024.12.002","article-title":"Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies","volume":"188","author":"Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium","year":"2025","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjo.2022.522","article-title":"Antidepressant prescribing patterns in Australia","volume":"8","author":"Malhi","year":"2022","journal-title":"BJPsych Open"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0435","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-026-03835-x","article-title":"TNF-\u03b1 and IFN-\u03b3 impair neural oscillations and induce neurodegeneration by microglial nitric oxide, metabolic and oxidative stress","volume":"23","author":"Malorny","year":"2026","journal-title":"Journal of Neuroinflammation"},{"issue":"10371","key":"10.1016\/j.pharmthera.2026.109121_bb0440","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","article-title":"Novel and emerging treatments for major depression","volume":"401","author":"Marwaha","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0445","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1038\/s41467-023-41750-4","article-title":"Ketamine evoked disruption of entorhinal and hippocampal spatial maps","volume":"14","author":"Masuda","year":"2023","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0450","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-70359-6","article-title":"Synchronous activation of striatal cholinergic interneurons induces local serotonin release","volume":"17","author":"Matityahu","year":"2026","journal-title":"Nature Communications"},{"issue":"37","key":"10.1016\/j.pharmthera.2026.109121_bb0455","article-title":"Spontaneous glutamate release activates mGluR signaling to drive rapid antidepressant responses","volume":"122","author":"McCarthy","year":"2025","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0460","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41380-018-0017-5","article-title":"Depression and obesity: Evidence of shared biological mechanisms","volume":"24","author":"Milaneschi","year":"2019","journal-title":"Molecular Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109121_bb0465","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","article-title":"The serotonin theory of depression: A systematic umbrella review of the evidence","volume":"28","author":"Moncrieff","year":"2023","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110037","article-title":"Navacaprant, a novel and selective kappa opioid receptor antagonist, has no agonist properties implicated in opioid-related abuse","volume":"257","author":"Morrison","year":"2024","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0475","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neuron.2025.01.002","article-title":"Projection-targeted photopharmacology reveals distinct anxiolytic roles for presynaptic mGluR2 in prefrontal- and insula-amygdala synapses","volume":"113","author":"Munguba","year":"2025","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0480","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/s41380-025-03341-1","article-title":"The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents","volume":"31","author":"Nadal-gratac\u00f3s","year":"2026","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107937","article-title":"Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders","volume":"229","author":"Newman-tancredi","year":"2022","journal-title":"Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0490","doi-asserted-by":"crossref","DOI":"10.1186\/s40345-023-00308-5","article-title":"NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: A randomized prospective phase 2 trial","volume":"11","author":"Nierenberg","year":"2023","journal-title":"International Journal of Bipolar Disorders"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0500","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.neuron.2025.12.004","article-title":"Synapse-specific and plasticity-regulated AMPA receptor mobility tunes synaptic integration","volume":"114","author":"Nowacka","year":"2026","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0505","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.celrep.2014.06.042","article-title":"Organization of monosynaptic inputs to the serotonin and dopamine neuromodulatory systems","volume":"8","author":"Ogawa","year":"2014","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2026.103120","article-title":"Metabolic and inflammatory roles of glial cells in neurodegenerative and cerebrovascular diseases","volume":"118","author":"Ogunleye","year":"2026","journal-title":"Ageing Research Reviews"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109121_bb0515","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1038\/s41380-025-03116-8","article-title":"Effects of antipsychotics on human cognitive function: Causal evidence from healthy volunteers following sustained D2\/D3 antagonism, D2\/D3 partial agonism and placebo","volume":"30","author":"Osugo","year":"2025","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0520","article-title":"Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents","volume":"9","author":"Otasowie","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0525","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-025-03451-1","article-title":"Diffuse traumatic brain injury induced stimulator of interferons (STING) signaling in microglia drives cortical neuroinflammation, neuronal dysfunction, and impaired cognition","volume":"22","author":"Packer","year":"2025","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0530","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41386-023-01721-1","article-title":"Novel neurosteroid therapeutics for post-partum depression: Perspectives on clinical trials, program development, active research, and future directions","volume":"49","author":"Patterson","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109121_bb0535","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.33339","article-title":"Neuromelanin-sensitive MRI contrast and chronic depression in Young women","volume":"8","author":"Perlman","year":"2025","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0540","doi-asserted-by":"crossref","first-page":"216","DOI":"10.20344\/amp.14304","article-title":"Suicide attempt in a patient with sibutramine associated psychosis","volume":"35","author":"Pestana","year":"2022","journal-title":"Acta M\u00e9dica Portuguesa"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108831","article-title":"Inflammatory bowel disease and neuropsychiatric disorders: Mechanisms and emerging therapeutics targeting the microbiota-gut-brain axis","volume":"269","author":"Petracco","year":"2025","journal-title":"Pharmacology and Therapeutics"},{"issue":"7989","key":"10.1016\/j.pharmthera.2026.109121_bb0550","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41586-023-06727-9","article-title":"Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2","volume":"623","author":"Pidathala","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0555","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.tins.2020.01.004","article-title":"Classification of midbrain dopamine neurons using single-cell gene expression profiling approaches","volume":"43","author":"Poulin","year":"2020","journal-title":"Trends in Neurosciences"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109121_bb0560","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa2304145","article-title":"Esketamine nasal spray versus quetiapine for treatment-resistant depression","volume":"389","author":"Reif","year":"2023","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0565","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.biopsych.2025.02.903","article-title":"Current evidence for the role of rapid-acting antidepressants in bipolar depression: A perspective and plan for action","volume":"98","author":"Repple","year":"2025","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0570","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-med-050423-095712","article-title":"Transformative therapies for depression: Postpartum depression, major depressive disorder, and treatment- resistant depression","volume":"76","author":"Richardson","year":"2025","journal-title":"Annual Review of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109121_bb0575","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/appi.ajp.20250721","article-title":"Intravenous brexanolone for the treatment of posttraumatic stress disorder: A case report","volume":"183","author":"Richardson","year":"2026","journal-title":"The American Journal of Psychiatry"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109121_bb0580","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamapsychiatry.2022.3384","article-title":"Evaluation of prefrontal \u03b3-aminobutyric acid and glutamate levels in individuals with major depressive disorder using proton magnetic resonance spectroscopy","volume":"79","author":"Ritter","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0585","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2020.09.001","article-title":"Psychological mechanisms and functions of 5-HT and SSRIs in potential therapeutic change: Lessons from the serotonergic modulation of action selection, learning, affect, and social cognition","volume":"119","author":"Roberts","year":"2020","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0590","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1176\/appi.ajp.20220504","article-title":"Adjunctive Cariprazine for the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled phase 3 study","volume":"180","author":"Sachs","year":"2023","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0595","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jad.2024.01.186","article-title":"Chronic exposure to imipramine induces a switch from depression-like to mania-like behavior in female serotonin transporter knockout rats: Role of BDNF signaling in the infralimbic cortex","volume":"351","author":"Sadighi","year":"2024","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108825","article-title":"The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targets","volume":"269","author":"Sah","year":"2025","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0605","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0610","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41562-023-01787-3","article-title":"A systematic review and meta-analysis of transdiagnostic cognitive behavioural therapies for emotional disorders","volume":"8","author":"Schaeuffele","year":"2024","journal-title":"Nature Human Behaviour"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109121_bb0615","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41386-024-01862-x","article-title":"Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI\/SNRI antidepressant in major depressive disorder: Results of a phase 2 randomized, double-blind, placebo-controlled study","volume":"49","author":"Schmidt","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"7904","key":"10.1016\/j.pharmthera.2026.109121_bb0620","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41586-022-04517-3","article-title":"Differential assembly diversifies GABAA receptor structures and signalling","volume":"604","author":"Sente","year":"2022","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109121_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abg3362","article-title":"Molecular mechanisms of metabotropic GABAB receptor function","volume":"7","author":"Shaye","year":"2021","journal-title":"Science Advances"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109121_bb0630","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.neuron.2026.04.023","article-title":"Cell- and state-specific plasticity of striatal glutamatergic synapses is critical to the expression of levodopa-induced dyskinesia","volume":"114","author":"Shen","year":"2026","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-023-02765-2","article-title":"Stellate ganglion block ameliorated central post-stroke pain with comorbid anxiety and depression through inhibiting HIF-1\u03b1\/NL","volume":"20","author":"Shi","year":"2023","journal-title":"Journal of Neuroinflammation"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109121_bb0640","doi-asserted-by":"crossref","first-page":"15116","DOI":"10.1021\/acsnano.5c22296","article-title":"Neutrophil-like mitochondria enable blood-brain barrier transmigration and neuroprotection","volume":"20","author":"Shin","year":"2026","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109121_bb0645","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41593-023-01519-w","article-title":"An ACC\u2013VTA\u2013ACC positive-feedback loop mediates the persistence of neuropathic pain and emotional consequences","volume":"27","author":"Song","year":"2024","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-70281-x","article-title":"A human cerebral organoid model of West Nile virus encephalitis shows innate immunocompetency","volume":"17","author":"Steffen","year":"2026","journal-title":"Nature Communications"},{"issue":"7981","key":"10.1016\/j.pharmthera.2026.109121_bb0655","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-023-06556-w","article-title":"Cryo-EM structures reveal native GABAA receptor assemblies and pharmacology","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14060709","article-title":"Targeting spermine oxidase to mitigate traumatic brain injury pathology in the aging brain","volume":"14","author":"Sun","year":"2025","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109121_bb0665","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.neuron.2025.03.018","article-title":"Dynorphin modulates reward-seeking actions through a pallido-amygdala cholinergic circuit","volume":"113","author":"Sun","year":"2025","journal-title":"Neuron"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.109121_bb0670","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1001\/jama.2022.22744","article-title":"Anxiety disorders: A review","volume":"328","author":"Szuhany","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0675","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40263-026-01297-6","article-title":"Restorative or disruptive? Effects of antidepressants on sleep architecture in depression","volume":"40","author":"Szynkarek","year":"2026","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0680","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bph.14074","article-title":"Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes\/macrophages","volume":"175","author":"Talmon","year":"2018","journal-title":"British Journal of Pharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109121_bb0685","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41593-023-01397-2","article-title":"The medial preoptic area mediates depressive-like behaviors induced by ovarian hormone withdrawal through distinct GABAergic projections","volume":"26","author":"Tao","year":"2023","journal-title":"Nature Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109121_bb0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjo.2023.15","article-title":"Dry mouth effects from drugs used for depression, anxiety, schizophrenia and bipolar mood disorder in adults: Systematic review","volume":"9","author":"Teoh","year":"2023","journal-title":"BJPsych Open"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124076","article-title":"Dual-functional tea polyphenol-serotonin nanoparticles for integrated inflammation suppression and mucosal repair in inflammatory bowel disease","volume":"331","author":"Tian","year":"2026","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0700","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1038\/s41467-025-65859-w","article-title":"Molecular mechanism of PINK1 regulation by the Hsp90 machinery","volume":"16","author":"Tian","year":"2025","journal-title":"Nature Communications"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109121_bb0705","article-title":"Human brain effects of DMT assessed via EEG-fMRI","volume":"120","author":"Timmermanna","year":"2023","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0710","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00018-024-05165-8","article-title":"The E3 ubiquitin ligase ITCH negatively regulates intercellular communication via gap junctions by targeting connexin43 for lysosomal degradation","volume":"81","author":"Totland","year":"2024","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109121_bb0715","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.biopsych.2025.10.036","article-title":"A comparison of positive and negative allosteric modulators of a 5-containing GABAA receptors in the treatment of affective disease","volume":"99","author":"Troppoli","year":"2026","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109121_bb0720","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2021.11.024","article-title":"Negative allosteric modulation of gamma-aminobutyric acid A receptors at \u03b15 subunit\u2013containing benzodiazepine sites reverses stress-induced anhedonia and weakened synaptic function in mice","volume":"92","author":"Troppoli","year":"2022","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11641-8","article-title":"Activating newborn neurons suppresses depression and anxiety-like behaviors","volume":"10","author":"Tunc-Ozcan","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0730","first-page":"1","article-title":"The prescriber\u2019s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression","volume":"15","author":"Van den Eynde","year":"2022","journal-title":"CNS Spectrums"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109121_bb0735","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41594-025-01666-7","article-title":"GluA4 AMPA receptor gating mechanisms and modulation by auxiliary proteins","volume":"32","author":"Vega-guti\u00e9rrez","year":"2025","journal-title":"Nature Structural & Molecular Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0740","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41746-025-01523-3","article-title":"Prediction of individual treatment allocation between electroconvulsive therapy or ketamine using the personalized advantage index","volume":"8","author":"Wade","year":"2025","journal-title":"NPJ Digit Medicine"},{"issue":"25","key":"10.1016\/j.pharmthera.2026.109121_bb0745","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1016\/j.cell.2025.10.022","article-title":"Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105542","article-title":"The receptor hypothesis and the pathogenesis of depression: Genetic bases and biological correlates","volume":"167","author":"Wang","year":"2021","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115545","article-title":"Novel antidepressant mechanism of hypericin: Role of connexin 43-based gap junctions","volume":"167","author":"Wang","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109121_bb0760","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41401-025-01515-9","article-title":"Ginsenoside Rg1 alleviates chronic stress-induced depression in rats by targeting Cx43-YAP axis","volume":"46","author":"Wang","year":"2025","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0765","article-title":"Astrocytic connexin 43 hemichannel dysregulation drives prefrontal circuit dysfunction and schizophrenia-like behaviors","author":"Wang","year":"2026","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0770","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41422-023-00906-z","article-title":"Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines","volume":"34","author":"Wang","year":"2024","journal-title":"Cell Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0775","first-page":"1","article-title":"Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy","volume":"12","author":"Wang","year":"2021","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109121_bb0780","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2018.11.007","article-title":"A new generation of antidepressants: An update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate\/GABA neurotransmitter systems","volume":"24","author":"Wilkinson","year":"2019","journal-title":"Drug Discovery Today"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109121_bb0785","article-title":"Brexanolone, zuranolone and related neurosteroid GABAA receptor positive allosteric modulators for postnatal depression","volume":"6","author":"Wilson","year":"2025","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0790","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41591-024-03305-y","article-title":"Home-based transcranial direct current stimulation treatment for major depressive disorder: A fully remote phase 2 randomized sham-controlled trial","volume":"31","author":"Woodham","year":"2025","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0795","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuron.2023.10.002","article-title":"Dopamine pathways mediating affective state transitions after sleep loss","volume":"112","author":"Wu","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0800","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbi.2022.12.014","article-title":"Hyper-inflammation of astrocytes in patients of major depressive disorder: Evidence from serum astrocyte-derived extracellular vesicles","volume":"109","author":"Xie","year":"2023","journal-title":"Brain, Behavior, and Immunity"},{"issue":"7854","key":"10.1016\/j.pharmthera.2026.109121_bb0805","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-021-03376-8","article-title":"Structural insights into the lipid and ligand regulation of serotonin receptors","volume":"592","author":"Xu","year":"2021","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2026.109121_bb0810","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177408","article-title":"Linking depression and neuroinflammation: Crosstalk between glial cells","volume":"995","author":"Yang","year":"2025","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0820","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.cell.2021.09.029","article-title":"SnapShot: Astrocyte interactions","volume":"185","author":"Yu","year":"2022","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109121_bb0825","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41593-020-00784-3","article-title":"Medial preoptic area antagonistically mediates stress-induced anxiety and parental behavior","volume":"24","author":"Zhang","year":"2021","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109121_bb0830","first-page":"1","article-title":"Novel antidepressant mechanism of ginsenoside Rg1 in regulating the dysfunction of the glutamatergic system in astrocytes","volume":"24","author":"Zhang","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109121_bb0835","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1038\/s41401-022-00861-2","article-title":"Connexin 43: Insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109121_bb0840","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1257617","article-title":"The pharmacological mechanism of chaihu-jia-longgu-muli-tang for treating depression: Integrated meta-analysis and network pharmacology analysis","volume":"14","author":"Zhao","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"8050","key":"10.1016\/j.pharmthera.2026.109121_bb0845","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-024-08454-1","article-title":"Resolving native GABAA receptor structures from the human brain","volume":"638","author":"Zhou","year":"2025","journal-title":"Nature"},{"issue":"6743","key":"10.1016\/j.pharmthera.2026.109121_bb0850","doi-asserted-by":"crossref","DOI":"10.1126\/science.adm8857","article-title":"A neuroimmune circuit mediates cancer cachexia-associated apathy","volume":"388","author":"Zhu","year":"2025","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109121_bb0855","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.apsb.2022.02.020","article-title":"Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention","volume":"12","author":"Zhu","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:17:18Z","timestamp":1794460638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826001488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":170,"alternative-id":["S0163725826001488"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109121","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting depression: Pharmacological mechanisms and therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109121"}}